Response by Kosiborod et al to Letters Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)". Issue 9 (27th February 2018) - Kosiborod, Mikhail; Cavender, Matthew A.; Fu, Alex Z.; Wilding, John P.; Khunti, Kamlesh; Holl, Reinhard W.; Norhammar, Anna; Birkeland, Kåre I.; Jørgensen, Marit Eika; Thuresson, Marcus; Arya, Niki; Bodegård, Johan; et al.